Login to Your Account

2,242 Trial Deaths, Few Rules: India Aims for Regulatory Reform

By Randy Osborne
Staff Writer

Monday, March 18, 2013
India's Drug and Cosmetics Act purports to keep clinical trials kosher under something called Schedule Y, but the law – which has not been amended since 2005 – lacks rules for mandatory practice and does not specify what recourse trial participants have when things go wrong.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription